Article Details
Retrieved on: 2018-02-10 02:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Man Group Plc</b> reported SC 13G/A form with the SEC for Orexigen Therapeutics, Inc. Access it here: 000090266418000791. As reported by <b>Man Group Plc</b>, the filler owns 8.13% or 1,524,143 shares of the Health Care–company.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here